Expression of olfactomedin 4 and claudin-18 in serrated neoplasia of the colorectum: A characteristic pattern is associated with sessile serrated lesion

Histopathology

Volumn 62, Issue 7, 2013, Pages 1018-1027

  Sentani, Kazuhiro ^a   Sakamoto, Naoya ^a   Shimamoto, Fumio ^b   Anami, Katsuhiro ^a   Oue, Naohide ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

Claudin 18; Olfactomedin 4; Serrated adenocarcinoma; Sessile serrated lesion

Indexed keywords

CLAUDIN 18; OLFACTOMEDIN 4; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; COLORECTAL CANCER; COLORECTAL POLYP; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA; SENSITIVITY AND SPECIFICITY;

ADENOMATOUS POLYPS; AGED; CLAUDINS; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84877925857     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12099     Document Type: Article

References (36)

1. Snover DC. Serrated polyps of the large intestine. Semin. Diagn. Pathol. 2005; 22; 301-308.
2. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119; 323-332.
3. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50; 113-130.
4. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 2003; 27; 65-81.
5. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am. J. Clin. Pathol. 2003; 119; 778-796.
6. Farris AB, Misdraji J, Srivastava A et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am. J. Surg. Pathol. 2008; 32; 30-35.
7. Ngo NT, Tan E, Tekkis P, Peston D, Cohen P. Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. Int. J. Colorect. Dis. 2010; 25; 1193-1200.
8. Torlakovic EE, Gomez JD, Driman DK et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am. J. Surg. Pathol. 2008; 32; 21-29.
9. Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod. Pathol. 2008; 21; 660-669.
10. Gibson JA, Hahn HP, Shahsafaei A, Odze RD. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Am. J. Surg. Pathol. 2011; 35; 742-749.
11. Schmitz KJ, Hey S, Schinwald A et al. Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Virchows Arch. 2009; 455; 49-54.
12. Tuppurainen K, Mäkinen JM, Junttila O et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J. Pathol. 2005; 207; 285-294.
13. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu. Rev. Pathol. 2009; 4; 343-364.
14. Yasui W, Oue N, Sentani K, Sakamoto N, Motoshita J. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol. Int. 2009; 59; 121-136.
15. Zhang X, Huang Q, Yang Z, Li Y, Li CY. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res. 2004; 64; 2474-2481.
16. Seko N, Oue N, Noguchi T et al. Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer. Exp. Ther. Med. 2010; 1; 73-78.
17. van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009; 137; 15-17.
18. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2001; 2; 285-293.
19. Zwiers A, Fuss IJ, Leijen S, Mulder CJ, Kraal G, Bouma G. Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflamm. Bowel Dis. 2008; 14; 1652-1659.
20. Matsuda M, Sentani K, Noguchi T et al. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis. Pathol. Int. 2010; 60; 673-680.
21. Sentani K, Oue N, Tashiro T et al. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am. J. Surg. Pathol. 2008; 32; 1182-1189.
22. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum. Pathol. 2011; 42; 1-10.
23. García-Solano J, Pérez-Guillermo M, Conesa-Zamora P et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum. Pathol. 2010; 41; 1359-1368.
24. Hamilton SR, Aaltonen LA (eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000; 104-111.
25. Oue N, Sentani K, Noguchi T et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int. J. Cancer 2009; 125; 2383-2392.
26. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J. Pathol. 2006; 208; 633-642.
27. O'Brien MJ, Yang S, Clebanoff JL et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am. J. Surg. Pathol. 2004; 28; 423-434.
28. Huang CS, O'Brien M J, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am. J. Gastroenterol. 2004; 99; 2242-2255.
29. Gray D, Obermann EC, Evans M, Hartmann A, Cooper K, Blaszyk H. MIB-1 and MCM-2 immunohistochemical analysis does not aid in identification of serrated colorectal polyps with abnormal proliferation. Am. J. Clin. Pathol. 2006; 125; 407-412.
30. Liu W, Liu Y, Zhu J, Wright E, Ding I, Rodgers GP. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin. Cancer Res. 2008; 14; 1041-1049.
31. Loh K, Chia JA, Greco S et al. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosom. Cancer 2008; 47; 449-460.
32. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006; 6; 186.
33. Fujita K, Hirahashi M, Yamamoto H et al. Mucin core protein expression in serrated polyps of the large intestine. Virchows Arch. 2010; 457; 443-449.
34. Yao T, Tsutsumi S, Akaiwa Y et al. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn. J. Cancer Res. 2001; 92; 755-761.
35. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int. J. Cancer 2008; 122; 1253-1260.
36. Tsukamoto T, Inada K, Tanaka H et al. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J. Cancer Res. Clin. Oncol. 2004; 130; 135-145.